AVTX Stock Analysis: Buy, Sell, or Hold?
AVTX - Avalo Therapeutics, Inc. Common Stock
$15.96
0.31 (1.98%)
▲
5d:
-0.62%
30d:
-6.23%
90d:
-11.48%
BUY
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Mar 19, 2026
Get Alerted When AVTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called AVTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AVTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: AVTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: AVTX is currently trading at $15.96, which is considered fair relative to its 30-day fair value range of $15.31 to $17.43.
Technical Outlook: Technically, AVTX is in a uptrend. Immediate support is located at $14.50, while resistance sits at $17.11.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $36.11 (+126.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AVTX is in a uptrend. Immediate support is located at $14.50, while resistance sits at $17.11.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $36.11 (+126.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$15.31 -
$17.43
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 126.3% below Wall St target ($36.11)
Fair Price Analysis
30-Day Fair Range
$15.31 -
$17.43
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$14.50
Resistance Level
$17.12
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.51
Wall Street Target
$36.11
(+126.3%)
Revenue Growth (YoY)
-66.4%
Last updated: February 03, 2026 8:03 PM ET
Data refreshes hourly during market hours. Next update: 9:03 PM
Data refreshes hourly during market hours. Next update: 9:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 61 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 63 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 59 HOLD |
